Germany Dna Diagnostics Market Size & Outlook, 2025-2030
Global Market
Related Markets
Germany dna diagnostics market highlights
- The Germany dna diagnostics market generated a revenue of USD 559.9 million in 2024 and is expected to reach USD 985.2 million by 2030.
- The Germany market is expected to grow at a CAGR of 9.8% from 2025 to 2030.
- In terms of segment, pcr-based diagnostics was the largest revenue generating technology in 2024.
- NGS DNA Diagnosis is the most lucrative technology segment registering the fastest growth during the forecast period.
Dna diagnostics market data book summary
| Market revenue in 2024 | USD 559.9 million |
| Market revenue in 2030 | USD 985.2 million |
| Growth rate | 9.8% (CAGR from 2025 to 2030) |
| Largest segment | Pcr-based diagnostics |
| Fastest growing segment | NGS DNA Diagnosis |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays-based Diagnostics, Other Technologies |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc |
Other key industry trends
- In terms of revenue, Germany accounted for 5.3% of the global dna diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany dna diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 985.2 million by 2030.
The DNA diagnostics market in Germany is propelled by significant investments in biotechnology and a strong healthcare system that prioritizes early disease detection & personalized treatment approaches. The country’s well-established infrastructure for medical research, along with a high level of public & private funding, fosters innovation in genetic testing technologies.
In addition, increasing public awareness of genetic disorders and the importance of early diagnosis are leading more individuals to seek DNA tests. Germany’s emphasis on preventive healthcare and the integration of genetic testing into standard medical practice contribute to market growth.
In Germany, the increasing rate of tuberculosis is one of the major factors promoting market growth. In Germany, around 4,076 cases of tuberculosis were reported in total in 2022. This is equivalent to 4.9 cases of tuberculosis per 100,000 people annually, according to a Federal Institute article released by the Robert Koch Institute.
No credit card required*
Publish Date: Oct 14, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
DNA Diagnostics Market Scope
DNA Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
Germany DNA Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to DNA Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Pcr-Based Diagnostics was the largest segment with a revenue share of 53.42% in 2024.
Horizon Databook has segmented the Germany dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
The DNA diagnostics market in Germany is propelled by significant investments in biotechnology and a strong healthcare system that prioritizes early disease detection & personalized treatment approaches. The country’s well-established infrastructure for medical research, along with a high level of public & private funding, fosters innovation in genetic testing technologies.
In addition, increasing public awareness of genetic disorders and the importance of early diagnosis are leading more individuals to seek DNA tests. Germany’s emphasis on preventive healthcare and the integration of genetic testing into standard medical practice contribute to market growth.
In Germany, the increasing rate of tuberculosis is one of the major factors promoting market growth. In Germany, around 4,076 cases of tuberculosis were reported in total in 2022. This is equivalent to 4.9 cases of tuberculosis per 100,000 people annually, according to a Federal Institute article released by the Robert Koch Institute.
- Germany Dna Diagnostics Market Technology Outlook (Revenue, USD Million , 2018-2030)
- PCR-based Diagnostics
- NGS DNA Diagnosis
- In-Situ Hybridization Diagnostics
- Microarrays-based Diagnostics
- Other Technologies
- Germany Dna Diagnostics Market Application Outlook (Revenue, USD Million , 2018-2030)
- Cancer Genetics Tests
- Infectious Diseases DNA Testing
- Newborn Genetic Screening
- Preimplantation & Reproductive Diagnosis
- Non-Infectious Diseases DNA Testing
- Prenatal DNA Carrier Screening
- Pharmacogenomics/Drug Metabolism
- Hematology & Immunology/Identity Diagnostics & Forensics
- Others
Reasons to subscribe to DNA Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of DNA Diagnostics Market Outlook databook
- Our clientele includes a mix of DNA Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany DNA Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Germany DNA Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Germany Dna Diagnostics Market, 2018-2030 (US$M)
Germany dna diagnostics market statistics, by technology, 2018-2030 (US$M)
